View in EDS

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.

Saved in:

Bibliographic Details
Title:	96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.
Authors:	Farrell, Michael¹ (AUTHOR) michael.farrell@unsw.edu.au, Shahbazi, Jeyran¹ (AUTHOR), Chambers, Mark¹ (AUTHOR), Byrne, Marianne^1,2 (AUTHOR), Gholami, Jaleh¹ (AUTHOR), Zahra, Emma¹ (AUTHOR), Grebely, Jason² (AUTHOR), Lintzeris, Nicholas^3,4 (AUTHOR), Larance, Briony^1,5 (AUTHOR), Ali, Robert^1,6 (AUTHOR), Nielsen, Suzanne^1,7 (AUTHOR), Dunlop, Adrian^8,9 (AUTHOR), Dore, Gregory J.² (AUTHOR), McDonough, Michael¹⁰ (AUTHOR), Montebello, Mark^1,3,11 (AUTHOR), Weiss, Rob¹² (AUTHOR), Rodgers, Craig¹³ (AUTHOR), Cook, Jon¹⁴ (AUTHOR), Degenhardt, Louisa¹ (AUTHOR)
Source:	International Journal of Drug Policy. May2024, Vol. 127, pN.PAG-N.PAG. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	09553959
DOI:	10.1016/j.drugpo.2024.104390